Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children

Blood (2025) 146 (Supplement 1): 738.

https://doi.org/10.1182/blood-2025-738

Published: 2025

Journal Articles

Treatment strategies and outcomes in pediatric patients with immune thrombocytopenia (ITP) undergoing surgical procedures: A multicenter study

Matthew Ross, Lia Phillips, Kristyn Pierce, Danielle Charland, Nour El Haouzi, Praharsha Konde, Matthew Meuler, Caitlin Montcrieff, Sara Ukropina, Karen Wang, Rachael Grace, Robert Klaassen, Michele Lambert, Thomas Pincez, Allison Remiker, Kirsty Hillier

Blood (2025) 146 (Supplement 1): 3046.

https://doi.org/10.1182/blood-2025-3046

Published: 2025

Journal Articles

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life

Gregory A. Abel, Robert Klaassen, Stephanie J. Lee, Nancy L. Young, Laura Cannella, David P. Steensma, Fabio Efficace

Blood (2014) 123 (3): 451–452.

https://doi.org/10.1182/blood-2013-11-540021

Published: 2014

Journal Articles

Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.

Rachael F. Grace, MD, Carolyn M. Bennett, MD, MS, A. Kim Ritchey, MD, Michael R. Jeng, MD, Courtney Thornburg, MD, MS, Michele Lambert, MD, Michelle Neier, MD, Michael Recht, MD, PhD, Manjusha Kumar, MD, Victor Blanchette, MD, Robert Klaassen, MD, FRCP, George R. Buchanan, MD, Margaret A. Heisel Kurth, MD, Diane J. Nugent, MD, Alexis A. Thompson, MD, MPH, Kimo Stine, MD, Leslie A. Kalish, ScD, Ellis J. Neufeld, MD, PhD

Blood (2010) 116 (21): 3681.

https://doi.org/10.1182/blood.V116.21.3681.3681

Published: 2010

Journal Articles

The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses

Rachael F. Grace, MD, Ellis J. Neufeld, MD, PhD, A. Kim Ritchey, MD, Manjusha Kumar, MD, Michael R. Jeng, MD, Victor Blanchette, MD, Robert Klaassen, MD, FRCP, George R. Buchanan, MD, Margaret A. Heisel Kurth, MD, Diane J. Nugent, MD, Alexis A. Thompson, MD, MPH, Courtney Thornburg, MD, MS, Michele P. Lambert, MD, Michelle D. Neier, MD, Michael Recht, MD, PhD, Kimo Stine, MD, Leslie A. Kalish, ScD, Carolyn M. Bennett, MD, MS

Blood (2010) 116 (21): 2509.

https://doi.org/10.1182/blood.V116.21.2509.2509

Published: 2010

Journal Articles

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Robert Klaassen, MD, John D. Grainger, MD, Arne Riedlinger, M.Phil., Victor S. Blanchette, MD, Tricia Burke, BA, Estela Citrin, MD, Gustavo Dufort y Alvarez, MD, Petronella Rachieru, MD, Josué Rakotonjanahary, MPH, Gerhard Gaedicke, MD, Cindy D. Wakefield, RN, Nancy L. Young, PhD

Blood (2009) 114 (22): 2501.

https://doi.org/10.1182/blood.V114.22.2501.2501

Published: 2009

Journal Articles

Genotyp-Phenotype Correlation in Congenital ADAMTS13 Deficient Patients

Luca Andrea Lotta, Isabella Garagiola, Andrea Cairo, Robert Klaassen, MD, FRCP, Ayse Metin, Aytemiz Gurgey, Flora Peyvandi

Blood (2008) 112 (11): 273.

https://doi.org/10.1182/blood.V112.11.273.273

Published: 2008

Journal Articles

Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

George Buchanan, MD, Leah Adix, BS, Robert Klaassen, MD, Ellis Neufeld, MD, Ph.D., Sherri Zimmerman, MD, Kimo Stine, MD

Blood (2004) 104 (11): 3030.

https://doi.org/10.1182/blood.V104.11.3030.3030

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

End-of-study results from the ICON3 pines trial, a phase 3, randomized trial of eltrombopag vs. standard first-line treatment for newly diagnosed immune thrombocytopenia in children

Treatment strategies and outcomes in pediatric patients with immune thrombocytopenia (ITP) undergoing surgical procedures: A multicenter study

Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life

Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.

The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses

Treatment Does Not Correlate with Quality of Life in Children with Immune Thrombocytopenic Purpura: Results From the KIT International Cross-Cultural Validation Study.

Genotyp-Phenotype Correlation in Congenital ADAMTS13 Deficient Patients

Quantitative Assessment of Drug Treatment Side Effects in Children with Idiopathic Thrombocytopenic Purpura (ITP).

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only